Ethical, Legal, and Social Implications (ELSI) Congress (U13, Clinical Trials Not Allowed)
ID: 356158Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $350K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356158

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-24-028.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Human Genome Research Institute (NHGRI), is inviting applications for funding to support the biennial Ethical, Legal, and Social Implications (ELSI) Congress, scheduled for 2026, 2028, and 2030. The objective of this funding opportunity (RFA-HG-24-028) is to foster collaboration within the multidisciplinary ELSI research community by providing a platform for sharing research findings, particularly for trainees and early career scholars, while ensuring inclusivity and representation from diverse backgrounds. The NHGRI plans to commit $350,000 for one award, with applications due by November 20, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-HG-24-028-Full-Announcement.html
    RFA-HG-24-028.html
    The National Institutes of Health (NIH), through the National Human Genome Research Institute (NHGRI), is inviting applications for funding to support the Ethical, Legal, and Social Implications (ELSI) Congress to be held biennially in 2026, 2028, and 2030. This funding opportunity (RFA-HG-24-028) aims to foster collaboration within the multidisciplinary ELSI research community by providing a platform for sharing research findings, especially for trainees and early career scholars. The selected awardee will manage the logistical aspects of the conferences, including venue selection, attendee registration, and abstract peer reviews. There is a strong emphasis on inclusivity, ensuring representation from diverse backgrounds and promoting safe environments free from discrimination and harassment. The NHGRI plans to commit $350,000 for one award, with applications due by November 20, 2024. The proposal emphasizes enhancing diversity, accessibility, and comprehensive dissemination of conference outcomes, which aligns with NIH's commitment to fostering an inclusive research environment.
    Similar Opportunities
    Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03), aimed at funding small-scale research projects that investigate the ethical, legal, and social dimensions of human genetics and genomics. This funding opportunity encourages innovative research that addresses the complexities and emerging questions associated with genomic advancements, particularly focusing on diverse populations and potential inequities in access and benefits. Eligible applicants include a wide range of entities such as higher education institutions, non-profits, and government agencies, with funding of up to $50,000 available per year for a maximum of two years. Applications will be accepted starting January 19, 2024, with various submission deadlines through 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)" to support research that investigates the ethical, legal, and social implications of human genetics and genomics. This grant encourages applications that utilize a variety of research methods, including empirical qualitative and quantitative approaches, to address significant ELSI issues arising from advancements in genomic technologies. The initiative aims to foster community engagement, particularly with historically underserved populations in genomic research, reflecting a commitment to ethical considerations in scientific progress. Grants of up to $275,000 are available for projects spanning two to three years, with application deadlines starting January 19, 2024, and funding decisions expected by July 2024. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program," aimed at fostering transdisciplinary ELSI research among underrepresented domestic organizations. The program seeks applications from entities that have received less than $30 million in NIH funding annually over the past three years, focusing on enhancing community engagement, building research capacity, and developing a diverse workforce in the field of genomics. With an anticipated funding amount of approximately $4.8 million for up to four awards, projects can last up to five years, and applicants must adhere to specific guidelines and deadlines, with submissions due by August 2, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Supporting Talented Early Career Researchers in Genomics," aimed at supporting innovative research projects led by Early Stage Investigators (ESIs) with a focus on genomics. This initiative encourages diverse applicants to propose research that aligns with the mission of the National Human Genome Research Institute (NHGRI), covering areas such as genomic sciences, genomic medicine, genomic data science, and the ethical implications of genomics. The program has a funding commitment of at least $2 million, with plans to award 3-5 grants, each with an annual budget cap of $400,000. Applications must be submitted electronically by February 26, 2027, and should include a detailed professional development plan and a resource sharing plan in compliance with NIH policies. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that enhance understanding of genomic data applications, assess implementation methods, and identify barriers to health equity, particularly for underrepresented groups. The R03 grant mechanism supports small research projects with a maximum budget of $50,000 per year, with an estimated total funding of approximately $150,000 for two awards in fiscal year 2024. Applications must be submitted electronically by February 12, 2025, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Reuse of NHGRI Data Assets" under the R03 Small Grant Program, aimed at promoting innovative research and secondary analysis projects utilizing genomic datasets from the National Human Genome Research Institute's (NHGRI) AnVIL platform. The initiative seeks to eliminate cost barriers for new users and enhance the utilization of NHGRI datasets, thereby stimulating further discovery in genomics research. Approximately $1 million will be allocated annually for up to seven awards, with each project having a budget limit of $125,000 in direct costs and a maximum project period of two years. Interested applicants must submit their proposals by January 14, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.